EXHIBIT 32.1
                                                                  ------------

                          CERTIFICATION PURSUANT TO
                           18 U.S.C. SECTION 1350,
                           AS ADOPTED PURSUANT TO
                SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of K-V Pharmaceutical Company (the
"Company") on Form 10-K for the fiscal year ended March 31, 2005, as filed
with the Securities and Exchange Commission on the date hereof (the
"Report"), I, Marc S. Hermelin, Vice Chairman and Chief Executive Officer of
the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

         (1)      The Report fully complies with the requirements of section
                  13(a) or 15(d) of the Securities Exchange Act of 1934; and

         (2)      The information contained in the Report fairly presents,
                  in all material respects, the financial condition and
                  results of operations of the Company.







                                               /s/ Marc S. Hermelin
                                    -----------------------------------------
                                                 Marc S. Hermelin
                                    Vice Chairman and Chief Executive Officer
Date: June 14, 2005                       (Principal Executive Officer)